ABL1 and neurodegenerative disease: Importantly, if the neurodegenerative disease process is dependent on activation of c‐Abl, with generation of pathologic forms of α‐synuclein through tyrosine phosphorylation, then the critical driver of the disease process resides inside the affected neurons.